Global Carfilzomib Market Witnesses Strong Growth Amidst Rising Cancer Treatment Demands – DataIntelo Report https://dataintelo.com/report/global-carfilzomib-market The Carfilzomib Market is poised for significant expansion as demand for advanced oncology therapeutics surges worldwide. According to a recent report by DataIntelo, the market is being propelled by a growing cancer patient population, technological advancements in proteasome inhibitors, and increasing investments in healthcare infrastructure. Carfilzomib, a second-generation proteasome inhibitor, is gaining rapid adoption due to its proven efficacy in treating relapsed and refractory multiple myeloma.